These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 27083388)
1. The role of acid-base imbalance in statin-induced myotoxicity. Taha DA; De Moor CH; Barrett DA; Lee JB; Gandhi RD; Hoo CW; Gershkovich P Transl Res; 2016 Aug; 174():140-160.e14. PubMed ID: 27083388 [TBL] [Abstract][Full Text] [Related]
2. Hyperlipidaemia alone and in combination with acidosis can increase the incidence and severity of statin-induced myotoxicity. Taha DA; Zgair A; Lee JB; de Moor CH; Barrett DA; Bruce KD; Sungelo M; Eckel RH; Gershkovich P Eur J Pharm Sci; 2017 Mar; 100():163-175. PubMed ID: 28104473 [TBL] [Abstract][Full Text] [Related]
3. Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization. Prueksaritanont T; Subramanian R; Fang X; Ma B; Qiu Y; Lin JH; Pearson PG; Baillie TA Drug Metab Dispos; 2002 May; 30(5):505-12. PubMed ID: 11950779 [TBL] [Abstract][Full Text] [Related]
4. Statin induced myotoxicity: the lactone forms are more potent than the acid forms in human skeletal muscle cells in vitro. Skottheim IB; Gedde-Dahl A; Hejazifar S; Hoel K; Asberg A Eur J Pharm Sci; 2008 Apr; 33(4-5):317-25. PubMed ID: 18294823 [TBL] [Abstract][Full Text] [Related]
5. Differential interaction of 3-hydroxy-3-methylglutaryl-coa reductase inhibitors with ABCB1, ABCC2, and OATP1B1. Chen C; Mireles RJ; Campbell SD; Lin J; Mills JB; Xu JJ; Smolarek TA Drug Metab Dispos; 2005 Apr; 33(4):537-46. PubMed ID: 15616150 [TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Lennernäs H; Fager G Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173 [TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein has differential effects on the disposition of statin acid and lactone forms in mdr1a/b knockout and wild-type mice. Chen C; Lin J; Smolarek T; Tremaine L Drug Metab Dispos; 2007 Oct; 35(10):1725-9. PubMed ID: 17640956 [TBL] [Abstract][Full Text] [Related]
8. Transport mechanism of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors at the blood-brain barrier. Tsuji A; Saheki A; Tamai I; Terasaki T J Pharmacol Exp Ther; 1993 Dec; 267(3):1085-90. PubMed ID: 8263769 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites. Menter DG; Ramsauer VP; Harirforoosh S; Chakraborty K; Yang P; Hsi L; Newman RA; Krishnan K PLoS One; 2011; 6(12):e28813. PubMed ID: 22216116 [TBL] [Abstract][Full Text] [Related]
10. Effects of acid and lactone forms of statins on S-warfarin 7-hydroxylation catalyzed by human liver microsomes and recombinant CYP2C9 variants (CYP2C9.1 and CYP2C9.3). Shiozawa A; Yamaori S; Kamijo S; Ohmori S Drug Metab Pharmacokinet; 2021 Feb; 36():100364. PubMed ID: 33341662 [TBL] [Abstract][Full Text] [Related]
11. Involvement of organic anion transporting polypeptides in the toxicity of hydrophilic pravastatin and lipophilic fluvastatin in rat skeletal myofibres. Sakamoto K; Mikami H; Kimura J Br J Pharmacol; 2008 Aug; 154(7):1482-90. PubMed ID: 18500364 [TBL] [Abstract][Full Text] [Related]
12. Study on the conversion of three natural statins from lactone forms to their corresponding hydroxy acid forms and their determination in Pu-Erh tea. Yang DJ; Hwang LS J Chromatogr A; 2006 Jun; 1119(1-2):277-84. PubMed ID: 16388814 [TBL] [Abstract][Full Text] [Related]
13. Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin. Thelen KM; Rentsch KM; Gutteck U; Heverin M; Olin M; Andersson U; von Eckardstein A; Björkhem I; Lütjohann D J Pharmacol Exp Ther; 2006 Mar; 316(3):1146-52. PubMed ID: 16282522 [TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory effects of hydrophilic and lipophilic statins with hyaluronic acid against LPS-induced inflammation in porcine articular chondrocytes. Chang CH; Hsu YM; Chen YC; Lin FH; Sadhasivam S; Loo ST; Savitha S J Orthop Res; 2014 Apr; 32(4):557-65. PubMed ID: 24302463 [TBL] [Abstract][Full Text] [Related]
15. Possible mechanisms underlying statin-induced skeletal muscle toxicity in L6 fibroblasts and in rats. Itagaki M; Takaguri A; Kano S; Kaneta S; Ichihara K; Satoh K J Pharmacol Sci; 2009 Jan; 109(1):94-101. PubMed ID: 19129682 [TBL] [Abstract][Full Text] [Related]
16. Statins with different lipophilic indices exert distinct effects on skeletal, cardiac and vascular smooth muscle. Irwin JC; Fenning AS; Vella RK Life Sci; 2020 Feb; 242():117225. PubMed ID: 31881229 [TBL] [Abstract][Full Text] [Related]
17. Potential risk of myopathy by HMG-CoA reductase inhibitors: a comparison of pravastatin and simvastatin effects on membrane electrical properties of rat skeletal muscle fibers. Pierno S; De Luca A; Tricarico D; Roselli A; Natuzzi F; Ferrannini E; Laico M; Camerino DC J Pharmacol Exp Ther; 1995 Dec; 275(3):1490-6. PubMed ID: 8531120 [TBL] [Abstract][Full Text] [Related]
18. Lipophilic statins suppress cytotoxicity by freshly isolated natural killer cells through modulation of granule exocytosis. Tanaka T; Porter CM; Horvath-Arcidiacono JA; Bloom ET Int Immunol; 2007 Feb; 19(2):163-73. PubMed ID: 17182966 [TBL] [Abstract][Full Text] [Related]
19. Coenzyme Q10 ameliorates the reduction in GLUT4 transporter expression induced by simvastatin in 3T3-L1 adipocytes. Ganesan S; Ito MK Metab Syndr Relat Disord; 2013 Aug; 11(4):251-5. PubMed ID: 23496027 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of smooth muscle cell calcium mobilization and aortic ring contraction by lactone vastatins. Escobales N; Crespo MJ; Altieri PI; Furilla RA J Hypertens; 1996 Jan; 14(1):115-21. PubMed ID: 12013483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]